Despite a parade of studies warning that treatment guidelines issued by professional medical societies fail to fully disclose potential financial conflicts, two new analyses report that the problem persists.
In one analysis, researchers found that 57 percent of 91 authors who developed 18 different guidelines for several big-selling medicines had financial conflicts, and 25 percent of the authors did not disclose a conflict in the guidelines or supplemental materials. The median undisclosed payment was $522, while the average was $17,000. Moreover, none of the guidelines were fully compliant with disclosure requirements issued by the National Academy of Medicine.
About the Author Reprints
